Domestic pharmaceutical giant Cipla has posted an increase of 40.94 per cent in its net profit for the quarter ended March, 2009, at Rs 252.92 crore compared with Rs 179.45 crore in the previous corresponding quarter.
Its net sales rose to Rs 1,235.17 crore during the quarter from Rs 1,081.62 crore last year, up 14.2 per cent.
On the annual basis, the company's net profit grew by 9.47 per cent to Rs 767.83 crore for the financial year ended March, 2009 from Rs 701.43 crore in the previous year.The net sales for the year stood at Rs 4,972.69 crore against Rs 3,997.90 crore last year, up 24.38 per cent.
On the Bombay Stock Exchange, the company's shares closed trading on Friday at Rs 239.35, up 3.59 per cent.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app